Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FB9TC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,683
Award facts
- Contract value 100% obligated
- $16,683.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 30, 2026, the Defense Logistics Agency awarded a $16,683.31 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes. This non-set-aside, firm fixed-price contract is expected to be completed by February 2, 2026, with performance taking place at the company's Corporate Office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and other inflammatory conditions, making it a critical pharmaceutical supply for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive vehicle for delivering a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. As a major pharmaceutical distributor serving the federal government on a competitive basis, Cencora and its subsidiary continue to fulfill essential medical procurement needs for the Defense Health Agency, United States Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FB9TC?
SPE2DR26FB9TC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FB9TC worth?
The government has obligated $16,683 on SPE2DR26FB9TC.
Is contract SPE2DR26FB9TC an order under another contract?
Yes. SPE2DR26FB9TC is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9TC competed?
The extent of competition for SPE2DR26FB9TC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award